Sleemon Healthy Sleep Technology Co., Ltd. (SHA:603008)
China flag China · Delayed Price · Currency is CNY
8.80
+0.25 (2.92%)
Sep 1, 2026, 3:00 PM CST

SHA:603008 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-55.25241.41322.36428.87237.55558.75
Depreciation & Amortization
244.6244.25258.87251.03243.73179.55
Other Amortization
184.75196.89179.66176.88103.591.61
Loss (Gain) From Sale of Assets
-1.030.01-0.121.450.02-0.01
Asset Writedown & Restructuring Costs
34.4432.2623.721.342.344.3
Loss (Gain) From Sale of Investments
19.914.66-9.31-16.4415.91-44.19
Provision & Write-off of Bad Debts
17.417.421.9851.3817.7954.12
Other Operating Activities
153.7598.3483.9584.83109.33115.42
Change in Accounts Receivable
106.0530.0533.65-24.59350.82-932.47
Change in Inventory
-9.58-2.5137.38157.77-98.07-303.08
Change in Accounts Payable
130.55-8.47-188.47157.13-99.89998.88
Operating Cash Flow
791.95840.92786.61,253841.29703.61
Operating Cash Flow Growth
-13.99%6.91%-37.23%48.95%19.57%-4.92%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-539.94-591.01-361.41-572.71-854.54-492.07
Sale of Property, Plant & Equipment
7.337.186.925.930.061.69
Cash Acquisitions
97.5-----
Divestitures
---909064.04
Investment in Securities
-41.21-3.4390.5710-16080.18
Other Investing Activities
-1,2238.924.617.949.1211.57
Investing Cash Flow
-1,699-578.35-93.32-243.33-805.64-334.59

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-3,9263,6422,6352,3931,944
Total Debt Issued
3,4583,9263,6422,6352,3931,944
Long-Term Debt Repaid
--3,762-3,284-3,335-2,088-1,810
Total Debt Repaid
-3,198-3,762-3,284-3,335-2,088-1,810
Net Debt Issued (Repaid)
259.91164.43357.44-699.45305.11134.81
Issuance of Common Stock
----159.82-
Repurchase of Common Stock
-124.49-124.49-79.99-200.02--190
Common Dividends Paid
-148.79-363.6-258.19-91.84-188.84-164.38
Other Financing Activities
-120.9-114.5-80.31228.2-306.85-27.05
Financing Cash Flow
-134.28-438.16-61.05-763.11-30.77-246.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-1,041-175.59632.23246.674.88122.4

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
252.01249.91425.19680.4-13.25211.54
Free Cash Flow Growth
-56.15%-41.23%-37.51%---59.91%
Free Cash Flow Margin
2.93%2.83%4.87%7.84%-0.17%2.72%
Free Cash Flow Per Share
0.690.671.121.76-0.040.55
Levered Free Cash Flow
-628.0215.25-6.12697.67-431.17949.07
Unlevered Free Cash Flow
-576.0767.242.63741.57-374.95990.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
295.91518.28406.68407.67433.29338.27
Change in Working Capital
193.39-4.29-94.49273.76111.12-255.94